Security Management White Papers

Orexigen Selects GlobalSign's DocumentSign Services to Secure Sensitive Documentation

Overview Orexigen Therapeutics, Inc. (Nasdaq: OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of Central Nervous System (CNS) disorders, including obesity. The challenge was seeking a more cost effective and secures solution of communicating, publishing and storing test results. GlobalSign's DocumentSign digital IDs are issued in conjunction with the Adobe Certified Document Services (CDS) program and governed by a rigorous standard established by Adobe, resulting in long-lasting, non-repudiated, instantly trusted and legally admissible signatures.

Further White Paper Details
PublisherGlobalSign & GMO Internet File FormatPDF
Date PublishedJuly 2008
FormatCase Studies   
Topics

Balancing Security Against Productivity

What makes for great security? Is it about keeping the bad guys out or letting the good guys in? About defending attacks or preventing them? When IDG Research Services queried...

Activate Today!Realize ROI with Intel® vPro Technology and Microsoft System Configuration Manager

Join the team from the Intel vPro Expert Center for an informative Webcast on the ROI savings and activation process for PCs with Intel® vPro™ technology and Microsoft System Configuration...

Animated Demo of vPro Systems

This animated demo shows how vPro offers security and manageability on the chip.

Tube Lines reaps rewards of upgrading to Intel®Core™2 processor with vPro™technology

Tube Lines has a 30-year Public Private Partnership (PPP) contract with London Underground. It is responsible for the maintenance and upgrade of the infrastructure on the Jubilee, Northern and Piccadilly...

Video Case Study: Verizon UK

This video case study looks at how Chris Maylor, head of architecture services at Verizon UK, went about implementing vPro.


Quick Sitemap Links: